Hypofunction of the stress axis in Sjogren's syndrome

Journal of Rheumatology

Volumn 25, Issue 8, 1998, Pages 1508-1514

  Johnson, Elizabeth O ^a   Vlachoyiannopoulos, Panayiotis G ^b,d   Skopouli, Fotini N ^c   Tzioufas, Athanasios G ^c   Moutsopoulos, Haralampos M ^c  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Department of Medicine ^*

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

ACTH; Cortisol; Sjogren's syndrome; Stress axis

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; THYROTROPIN;

ADRENAL FUNCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DISEASE ASSOCIATION; FEMALE; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; SJOEGREN SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANIMALS; AUTOANTIBODIES; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SHEEP; SJOGREN'S SYNDROME; STRESS; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 0031880285     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Johnson EO, Kamilaris TC, Chrousos GP, Gold PW. Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev 1992;16:115-30.
2. Chrousos GP, Gold PW. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992;267:1244-52.
3. Johnson EO, Moutsopoulos HM. Neuroimmunological axis and rheumatic diseases [editorial]. Eur J Clin Invest 1992;22:2-5.
4. Sternberg EM. Hypoimmune fatigue syndromes: diseases of the stress response? [editorial]. J Rheumatol 1993;20:418-21.
5. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;177:854-66.
6. Cash JM, Crofford LJ, Gallucci WT, et al. Pituitary-adrenal axis responsiveness to ovine CRH in patients with rheumatoid arthritis treated with low-dose prednisone. J Rheumatol 1992;19:1692-7.
7. Chikanza IC, Chrousos G, Panayi GS. Abnormal neuroendocrine immune communications in patients with rheumatoid arthritis [commentary]. Eur J Clin Invest 1992;22:635-7.
8. Neek G, Federlin K, Graif V, Rusch D, Schmidt K. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990;17:24-9.
9. Blowers LE, Jayson MI, Jasani MK. Dexamethasone modulated protein synthesis in polymorphonuclear leukocytes: response in rheumatoid arthritis. J Rheumatol 1988;15:785-90.
10. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 1992;35:740-4.
11. Klein A, Buskila D, Gladman D, Bruser B, Malkin A. Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 1990;17:30-3.
12. Moutsopoulos HM, Chused TM, Mann DL, et al. Sjögren's syndrome (Sicca syndrome). Ann Intern Med 1980;92:212-26.
13. Moutsopoulos HM, Velthuis PJ, De Wilde PCM, Kater L. Sjögren's syndrome. In: Kater L, Baart dela Faille E, editors. Multi-systemic autoimmune diseases. An integrated approach. Amsterdam: Elsevier Science; 1995:173-205.
14. Strand V, Talal N. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1980;30:1046-52.
15. Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren's syndrome: clinical and immunological aspects. Berlin: Springer-Verlag; 1987.
16. Drosos AA, Andonopoulos AP, Lagos G, Angelopoulos NV, Moutsopoulos HM. Neuropsychiatrie abnormalities in primary Sjögren's syndrome. Clin Exp Rheumatol 1989;7:207-9.
17. Britton DR, Kood GF, Rivier J, Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 1982;31:363-7.
18. Britton DR, Lee G, Dana R, Risch SC, Koob GF. Activating and "anxiogenic" effects of corticotropin-releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci 1986;39:1281-6.
19. Nemeroff CB. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. J Clin Psychiatry 1989;50 Suppl: 13-20.
20. Vissel TJ, Laberts SEJ. Regulation of TSH secretion and thyroid function in Cushing's disease. Acta Endocrinol 1981;96:480-3.
21. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Diagnostic criteria for Sjögren's syndrome. Results of a European prospective multicentre study. Arthritis Rheum 1992;36:340-7.
22. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968;21:656-60.
23. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
24. Humbel RL. Detection of antinuclear antibodies by immunofluorescence. In: Van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease. The Netherlands: Kluwer Academic; 1993;A2:1-16.
25. Bunn C, Kveder T. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In: Van Venrooij WJ, Maini RN, editors. Manual of biological markers of disease. The Netherlands: Kluwer Academic; 1993;A3:1-12.
26. Hill SR, Ullao A, Starness WR, Holley AL. Corticosteroids in rheumatoid arthritis. Arch Intern Med 1963;112:603-11.
27. Pal SB. The secretion rate of cortisol in patients with rheumatoid arthritis. Clin Chim Acta 1970;29:129-37.
28. Mastorakos G, Chrousos GP. Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993;77:1690-4.
29. Crofford LJ, Kalogeras KT, Mastorakos G, et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997;82:1279-83.
30. Sternberg EM, Hill JM, Chrousos GP, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
31. Sternberg EM, Young WS III, Bernardini R, et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771-5.
32. Sternberg EM, Glowa JR, Smith MA, et al. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats. Brain Res 1992;570:54-60.
33. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-34.
34. Gold PW, Loriaux DL, Roy A, et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 1986;314:1329-35.
35. Vanderpool J, Rosenthal N, Chrousos GP, Wehr T, Gold PW. Evidence for hypothalamic CRH deficiency in patients with seasonal affective disorder. J Clin Endocrinol Metab 1991;72:1382-7.
36. Kamilaris TC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 1987;65:994-9.
37. Kamilaris TC, DeBold CR, Johnson EO. Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 1991;128:2567-76.
38. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. I. N Engl J Med 1988;319:384-93.
39. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. II. N Engl J Med 1988;319:413-20.
40. Karsh J, Pavlidis N, Weintraub BD, Moutsopoulos HM. Thyroid disease in Sjögren's syndrome. Arthritis Rheum 1980;23:1326-9.
41. Chikanza IC, Panayi GS. Hypothalamic-pituitary mediated modulation of immune function: prolactin as a neuroimmune peptide. Br J Rheumatol 1991;30:203-7.